HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

883.541

+5.0540.58%

Number of Gainers:9

Number of Losers:8

Number of Flat:- -

PE:- -

High:886.877

Open:878.433

Low:868.104

Close:878.487

Volume:235.21M

Turnover:1.73B

Market Cap:596.99B

Float Cap:494.48B

Loading ...

Sino Biopharm CEO Tse Says AI, Internationalization Anchor Counter-Cyclical Growth Strategy

Hong Kong Stock Market Update | SBP GROUP (01177) Climbs Nearly 3% After TQC3721 Inhalation Powder Data Presented at ERS 2026

Hong Kong Stock Market Alert | ALEBUND-B (09637) Surges Over 6% on Stock Connect Inclusion and Index Membership, Mircera Sales Jump Approximately 105% Boosting Commercial Momentum

Market Bets on BOJ Rate Hike While CICC's Merger Wins Regulatory Approval

Major Shift in Sell-Side Research: Healthcare Analyst Switches to Semiconductors

CSPC Pharma Begins Phase II Study of Influenza Drug in China

MT Newswires Live

Fourth Breakthrough Therapy Designation Granted to EGFR-Targeted ADC Developed by CSPC

CSPC Pharma Initiates Phase II Trial of SYH2085 Tablet for Uncomplicated Influenza in Chinese Adults

Jinan Pingjia's 60% Stake Relisted at 24 Million Yuan After Once Being Valued at 154 Million

Sino Biopharma Reports Phase I Data Showing Tqc3721 Dry Powder Inhaler Boosts COPD Lung Function in Dose-Ranging Trial

Fosun Pharma Spends HK$1.18M on Share Buyback on September 7

Sinopharm Group Stock Rallies 0.9% in Hong Kong

JD Health International Stock Slips 0.9% in Hong Kong

Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors

BYD Electronic (International) Stock Advances 6.8% in Hong Kong

Ascletis Pharma Joins Two Chinese Stock Connect Programs

MT Newswires Live

Kintor Pharma Shares Rise as Skin Tone Treatment Inches Closer to Approval After Trial Results

MT Newswires Live

Fosun Pharmaceutical Extends Deadline of 81 Million Yuan Shareholder Loans to Fuyun Health; Shares Up 7%

MT Newswires Live

Ascletis Announces Inclusion in the Hong Kong Stock Connect List Under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs

THOMSON REUTERS

UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/BK1515/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":883.54144,"timestamp":1789631679223,"preClose":878.48724,"halted":0,"volume":235214983,"delay":0,"changeRate":0.005753,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":5.054199,"latestTime":"09-17 15:54:39","open":878.4325,"high":886.8771,"low":868.10425,"amount":1734259749,"amplitude":0.021369,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789632600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"pbRate":1.317311,"peRate":17.071131,"turnoverRate":0.003222,"increases":9,"decrements":8,"flats":0,"marketCap":596991541312,"floatMarketCap":494484360192},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":886.8771,"amplitude":0.021369,"preClose":878.48724,"low":868.10425,"pbRate":"1.317311","latestPrice":883.54144,"volume":235214983,"delay":0,"open":878.4325,"prevYearClose":1190.107,"prevWeekClose":878.789,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":890.408,"twentyDayClose":941.274,"sixtyDayClose":813.549,"secType":"PLATE","market":"HK","turnoverRate":0.003222,"peRate":17.071131,"marketCap":596991541312,"floatMarketCap":494484360192,"timestamp":1789631679223,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":9,"down":8,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665341408","title":"Sino Biopharm CEO Tse Says AI, Internationalization Anchor Counter-Cyclical Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2665341408","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665341408?lang=en_us&edition=fundamental","pubTime":"2026-09-08 11:51","pubTimestamp":1788839513,"startTime":"0","endTime":"0","summary":"Sino Biopharm CEO Tse says AI, internationalization anchor counter-cyclical growth strategySino Biopharmaceutical CEO Eric Tse told the Yabuli Forum on Sept. 5 it is pursuing counter-cyclical growth t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL2RNzg9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2293690082.USD","LU0640478417.SGD","LU0963555726.SGD","LU1153585028.USD","LU0949170426.SGD","LU0969580561.USD","LU0738911758.USD","LU1019632923.USD","LU0211326755.USD","LU1863844749.USD","IE00BFTCPJ56.SGD","LU1267930813.SGD","LU2091194634.USD","LU0011850046.USD","BK1515","LU0784385840.USD","LU2433249047.HKD","LU1863844665.USD","LU0882574055.USD","LU0077335932.USD","LU0158827948.USD","LU0029864427.USD","BK5011","LU1051770623.HKD","LU0827474353.SGD","LU0960981461.USD","AZN.UK","01177","LU0128525689.USD","LU0972486137.USD","LU2237443978.SGD","LU2279689827.SGD","LU0345777659.USD","LU2125909247.SGD","LU1323610961.USD","LU0211328371.USD","LU0859254822.USD","LU0889566641.SGD","LU1355424745.HKD","IE00BZ08YS42.EUR","LU0887340254.USD","LU0052756011.USD","03165","LU0047473722.SGD","LU1119994496.HKD","LU2133065610.SGD","HK0000165453.HKD","LU0211327993.USD","LU1196032939.SGD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184154136","title":"Hong Kong Stock Market Update | SBP GROUP (01177) Climbs Nearly 3% After TQC3721 Inhalation Powder Data Presented at ERS 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1184154136","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184154136?lang=en_us&edition=fundamental","pubTime":"2026-09-08 10:50","pubTimestamp":1788835817,"startTime":"0","endTime":"0","summary":"Shares of SBP GROUP (01177) advanced nearly 3% in Hong Kong trading, last up 2.74% at HK$5.62 with turnover reaching HK$111 million.On September 7, the company announced that its subsidiary, Chia Tai...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","BK4588","HK0000165453.HKD","BK1521","KCAI","BK1589","VXUS","IE00BZ08YS42.EUR","BK4585","01177","BK1191","IE00BZ08YR35.GBP","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183000307","title":"Hong Kong Stock Market Alert | ALEBUND-B (09637) Surges Over 6% on Stock Connect Inclusion and Index Membership, Mircera Sales Jump Approximately 105% Boosting Commercial Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1183000307","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183000307?lang=en_us&edition=fundamental","pubTime":"2026-09-08 10:22","pubTimestamp":1788834140,"startTime":"0","endTime":"0","summary":"ALEBUND-B (09637) shares climbed more than 6% in Monday's session, trading up 6.02% at HK$28.52 as of the time of writing. The stock recorded a turnover of HK$6.452 million with a volume ratio of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","FLHK","HSCI","KCAI","BK1191","BK4585","09637","BK1574","09939","VXUS","BK4588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161695676","title":"Market Bets on BOJ Rate Hike While CICC's Merger Wins Regulatory Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1161695676","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161695676?lang=en_us&edition=fundamental","pubTime":"2026-09-08 07:46","pubTimestamp":1788824797,"startTime":"0","endTime":"0","summary":"The National Copyright Administration has issued the \"15th Five-Year Plan for Copyright Work,\" outlining key targets through 2030. The plan sets a national work registration target of 9.5 million...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EFAS","BK1147","WCMI","IAGG","BK1516","HDMV","IDVY","BK4585","UIVM","LU1580142542.USD","IE0008368742.USD","LU1960683339.HKD","IE00B543WZ88.USD","DIVI","BBIN","IE00B5MMRT66.SGD","LU0359202008.SGD","SG9999004220.SGD","BK1193","CGXU","FDT","LU1328277881.USD","BK1109","DBAW","IE00BZ08YS42.EUR","IDHQ","LU1226288170.HKD","OSEA","FDEV","LU0140636845.USD","03908","FEOE","IQSI","BK1564","09976","IE00B031HY20.USD","PCIG","IJAN","FNDC","MTRA","PJIO","QLVD","JIDE","LU1781817850.SGD","BK0276","AFDM","LU0072913022.USD","LU2663582299.SGD","LU1508157978.USD","BK1191","IBUF","LU0315179316.USD","SG9999002828.SGD","IHDG","LU1807302812.USD","LU0880133367.SGD","FIDI","BK1533","BUFI","IE00BZ08YT58.USD","IFEB","BK1122","LU1152091754.HKD","BCIL","JDVI","VDV","DFAI","LU0067412154.USD","LU0359201612.USD","OAKI","CVIE","GWX","601995","IBFR","GAID","PIEQ","DISV","EPIN","PDN","LU1813983027.USD","IFLO","AVDE","IE00BZ08YR35.GBP","LU0501845795.SGD","JHMD","LU1226287875.USD","BK1515","IQDG","HK0000165453.HKD","NIHI","NISM","IDLB","09678","LU1655091616.SGD","BK4550","LU2039709279.SGD","TLTD","EFV","BK1249","PDEV","DFGX","DIHP","BK1521","YJUN","AVIV","HDEF","DFIV","LU1152091168.USD","HSCZ","LU1951186391.HKD","REFA","IDLV","LU1226288253.USD","KURE","LU1993786604.SGD","EFAV","LU1226287792.SGD","YDEC","HJPX","IQLT","03308","IAUG","BK1149","IDYN","BK4588","EFAD","DMRI","IJUL","KCAI","LU1226287529.USD","RINT","NTSI","DNL","BK1501","01093","LU0326950275.SGD","LU1255011170.USD","RFDI","IDHD","VIGI","LU0314109678.HKD","EXUS","IE0008369823.USD","VXUS","FNDF","LU0359201885.HKD","DWM","LU1023057109.AUD","IVSX","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169256250","title":"Major Shift in Sell-Side Research: Healthcare Analyst Switches to Semiconductors","url":"https://stock-news.laohu8.com/highlight/detail?id=1169256250","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169256250?lang=en_us&edition=fundamental","pubTime":"2026-09-07 22:10","pubTimestamp":1788790245,"startTime":"0","endTime":"0","summary":"Sell-side research has witnessed a notable career pivot as a healthcare-focused analyst has transitioned to covering the electronics sector, marking a significant departure from their academic and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","KCE","BK1161","159938","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665142623","title":"CSPC Pharma Begins Phase II Study of Influenza Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2665142623","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665142623?lang=en_us&edition=fundamental","pubTime":"2026-09-07 21:11","pubTimestamp":1788786661,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group (HKG:1093) began a phase II clinical trial of SYH2085 tablets in China.The drug was developed by the company to treat uncomplicated influenza in adults, according to a Monday bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1993786604.SGD","LU1152091168.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU1807302812.USD","LU1226288253.USD","KURE","LU1226288170.HKD","IE00BZ08YS42.EUR","LU0501845795.SGD","LU1226287875.USD","LU1960683339.HKD","BK1191","LU1008478684.HKD","LU1152091754.HKD","LU1226287792.SGD","LU0067412154.USD","IE00B031HY20.USD","HK0000165453.HKD","LU2039709279.SGD","01093","LU0072913022.USD","BK1515","IE0008369823.USD","LU0315179316.USD","LU0326950275.SGD","LU0314109678.HKD","SG9999004220.SGD","BK1521","LU0140636845.USD","LU1226287529.USD","IE00BZ08YR35.GBP","IE0008368742.USD","LU0880133367.SGD","LU1813983027.USD","LU1328277881.USD","IE00BZ08YT58.USD","LU1951186391.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111207955","title":"Fourth Breakthrough Therapy Designation Granted to EGFR-Targeted ADC Developed by CSPC","url":"https://stock-news.laohu8.com/highlight/detail?id=1111207955","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111207955?lang=en_us&edition=fundamental","pubTime":"2026-09-07 21:01","pubTimestamp":1788786078,"startTime":"0","endTime":"0","summary":"On September 7th, the CDE website revealed that SYS6010, developed by CSPC PHARMA, has been proposed for inclusion in the breakthrough therapy designation program. This designation is intended for...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1008478684.HKD","LU0314109678.HKD","LU0326950275.SGD","LU1226288253.USD","SG9999004220.SGD","IE00BZ08YS42.EUR","LU1993786604.SGD","BK1191","LU0072913022.USD","LU1807302812.USD","LU1226287529.USD","LU0315179316.USD","LU1152091168.USD","LU1226287792.SGD","BK1515","LU1813983027.USD","LU1951186391.HKD","LU1152091754.HKD","LU1328277881.USD","HK0000165453.HKD","LU1226287875.USD","IE0008368742.USD","IE00BZ08YR35.GBP","LU0067412154.USD","LU0501845795.SGD","LU0880133367.SGD","IE00B5MMRT66.SGD","LU0140636845.USD","KURE","01093","IE00B543WZ88.USD","LU1226288170.HKD","IE00B031HY20.USD","BK1521","IE00BZ08YT58.USD","LU1960683339.HKD","IE0008369823.USD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199113939","title":"CSPC Pharma Initiates Phase II Trial of SYH2085 Tablet for Uncomplicated Influenza in Chinese Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=1199113939","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199113939?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:36","pubTimestamp":1788780985,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that the Phase II clinical trial of its SYH2085 tablet, designed for the treatment of uncomplicated influenza in adults, has formally commenced at the first clinical...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287792.SGD","LU1807302812.USD","LU1951186391.HKD","IE00B5MMRT66.SGD","LU1152091168.USD","IE00BZ08YR35.GBP","SG9999004220.SGD","LU1813983027.USD","LU1226287875.USD","LU0880133367.SGD","LU1226288170.HKD","KURE","IBBJ","IE00BZ08YS42.EUR","IE00B031HY20.USD","LU1008478684.HKD","BMED","BK1191","BK1521","LU1960683339.HKD","LU0501845795.SGD","01093","LU0140636845.USD","LU0072913022.USD","MDTX","IE00BZ08YT58.USD","BK1515","IE00B543WZ88.USD","LU2039709279.SGD","HK0000165453.HKD","PSYK","LU1328277881.USD","LU0067412154.USD","IBBQ","LU0314109678.HKD","LU0315179316.USD","LU1226287529.USD","LU0326950275.SGD","IE0008368742.USD","LU1152091754.HKD","IE0008369823.USD","LU1993786604.SGD","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135498525","title":"Jinan Pingjia's 60% Stake Relisted at 24 Million Yuan After Once Being Valued at 154 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1135498525","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135498525?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:21","pubTimestamp":1788780087,"startTime":"0","endTime":"0","summary":"More than two years have passed since the failed acquisition, and the 60% equity stake in Jinan Pingjia is once again on the property rights trading market, now with a minimum listing price of 24...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","BK1515","301017","BK0209","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665163383","title":"Sino Biopharma Reports Phase I Data Showing Tqc3721 Dry Powder Inhaler Boosts COPD Lung Function in Dose-Ranging Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665163383","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665163383?lang=en_us&edition=fundamental","pubTime":"2026-09-07 18:36","pubTimestamp":1788777372,"startTime":"0","endTime":"0","summary":"Sino Biopharma reports Phase I data showing TQC3721 dry powder inhaler boosts COPD lung function in dose-ranging trialSino Biopharmaceutical reported Phase I data for its inhaled COPD drug candidate T","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL6f08vl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1589","01177","BK1521","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1191","BK1515","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146341626","title":"Fosun Pharma Spends HK$1.18M on Share Buyback on September 7","url":"https://stock-news.laohu8.com/highlight/detail?id=1146341626","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146341626?lang=en_us&edition=fundamental","pubTime":"2026-09-07 18:02","pubTimestamp":1788775333,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. (HK: 02196) has announced a share repurchase transaction executed on September 7, 2026. According to the company's official disclosure, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0175","BK0196","BK1191","BK1515","600196","BK0183","02196","BK0012","BK0060","BK0096","BK0187","BK0188","BK0028","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665900313","title":"Sinopharm Group Stock Rallies 0.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665900313","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665900313?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:33","pubTimestamp":1788769980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. inched 0.9% higher to 15.83 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's third consecutive day of gains.Sinopharm Group Co. Ltd. closed 29% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 7.1%.Trading volume totaled 4.5 million shares, compared to the 50-day average of 5.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0196","BK1515","BK4175","02196","BK0239","LU1115378108.SGD","BK1593","LU0640798160.USD","BK1191","BK0060","01099","BK0096","600196","BK0028","BK1197","BK0187","BK0183","BK0188","BK1500","BK0175","SHTDY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665033390","title":"JD Health International Stock Slips 0.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665033390","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665033390?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:33","pubTimestamp":1788769980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. dropped 0.9% to 36.74 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.JD Health International Inc. closed 49% short of its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 4.6 million shares, compared to the 50-day average of 10.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1247","06618","SGXZ62798434.SGD","LU0456827905.SGD","BK1142","BK1515","LU0051755006.USD","BK1615","BK1583","86618","SGXZ86797644.SGD","BK1571","BK1591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665739003","title":"Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665739003","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665739003?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:32","pubTimestamp":1788769920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.2% to 5.47 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 40% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.1% and Amgen Inc. remained unchanged.Trading volume totaled 42.8 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU1023059063.AUD","IE00B2B36J28.USD","LU0122379950.USD","IE00B4R5TH58.HKD","LU0058720904.USD","BK4581","IE0009355771.USD","LU1571399168.USD","LU2242652126.USD","TBXU","LU2089984988.USD","LU2242646821.SGD","BK4585","LU1983299246.USD","BK1191","IE00BZ08YT58.USD","LU2468319806.SGD","BK4533","LU0320765992.SGD","BK4599","01177","IE00BJT1NW94.SGD","IE00BZ08YS42.EUR","BK4534","LU0868494617.USD","LU1061106388.HKD","BK1521","BK4139","LU0289739699.SGD","BK4566","BK4588","BK1515","IBBQ","PJP","PBE","LU0889565916.HKD","BBH","BK1589","LU1057294990.SGD","SG9999001440.SGD","IE0002141913.USD","LU2112291526.USD","BIB","AMGN","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","HK0000165453.HKD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390776","title":"BYD Electronic (International) Stock Advances 6.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390776","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665390776?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:30","pubTimestamp":1788769800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of BYD Electronic  Co. Ltd. rallied 6.8% to 26.88 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's second consecutive day of gains.BYD Electronic  Co. Ltd. closed 40% below its 52-week high of HK$44.60, which the company reached Oct. 2.The stock outperformed some of its competitors, as Times Universal Group Holdings Ltd. remained unchanged.Trading volume totaled 19.6 million shares, compared to the 50-day average of 12.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1540","LU0274383008.USD","BK1504","BK1149","BK1167","BK1589","00285","BK1515","LU0348766576.USD","LU0348767384.USD","BK1580","BK1582","BK1607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665474394","title":"Ascletis Pharma Joins Two Chinese Stock Connect Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665474394","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665474394?lang=en_us&edition=fundamental","pubTime":"2026-09-07 14:34","pubTimestamp":1788762852,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  said it has been included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective Sept. 7.The inclusion allows mainland Chinese investors to trade the biotech company's Hong Kong-listed shares through the Stock Connect platform, according to a Monday Hong Kong bourse filing.Shares of the drugmaker rose over 2% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02823","BK1515","XPP","02843","82823","KBA","ASHS","YINN","ASHR","82822","YXI","KCAI","KWEB","CWEB","82843","BK1574","01672","BK1161","02822","YANG","CHAU","FXP","FLCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665992903","title":"Kintor Pharma Shares Rise as Skin Tone Treatment Inches Closer to Approval After Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665992903","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665992903?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:11","pubTimestamp":1788757872,"startTime":"0","endTime":"0","summary":"Kintor Pharmaceutical  has disclosed positive results from the long-term safety trial of its skin tone correcting treatment, KT-939, according to a Monday bourse filing.Preliminary data showed that KT-939 was safe and well-tolerated, and participants treated with it for about a year did not experience any adverse skin reactions, the company said.Kintor said it is now working to advance KT-939's registration application for approval by the National Medical Products Administration before launching it commercially.The company's shares are up 5.5% in midday trading on the HKEX.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09939","BK1574","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665992823","title":"Fosun Pharmaceutical Extends Deadline of 81 Million Yuan Shareholder Loans to Fuyun Health; Shares Up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665992823","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665992823?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:05","pubTimestamp":1788757530,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical , along with its controlling shareholder and subsidiaries, agreed to extend the shareholder loans worth 80.8 million yuan provided to Fuyun Health for another year, according to a Shanghai bourse filing over the weekend.The Chinese pharmaceutical company's Hong Kong shares jumped 7%, while Shanghai shares rose 1% during Monday's midday trade.The loans' extended maturity date will be Sept. 4, 2027, and the annual interest rate during the extension period will remain at 3.2%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK1515","BK1593","BK0096","BK0196","BK0188","BK0187","02196","BK1191","BK0183","BK0175","600196","BK0060","BK0012","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399806","title":"Ascletis Announces Inclusion in the Hong Kong Stock Connect List Under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399806","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399806?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:15","pubTimestamp":1788754501,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nTUABQ4B5D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1161","01672","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109390642","title":"UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1109390642","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109390642?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:50","pubTimestamp":1788745830,"startTime":"0","endTime":"0","summary":"UBS has released a research note suggesting that while market expectations for the Chinese biotech sector's first-half results were initially conservative—due to concerns over tighter domestic drug...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1583","LU0326950275.SGD","BK1588","01801","IE00B5MMRT66.SGD","LU1251922891.USD","LU1720050803.USD","LU1719994722.HKD","LU1961090484.USD","LU2476274720.SGD","03069","LU1794554557.SGD","IE00B543WZ88.USD","LU0348766576.USD","BK4585","LU0348783233.USD","LU0228659784.USD","LU0463099449.HKD","LU2097828474.EUR","LU2476274308.USD","LU0561508036.HKD","BK1589","LU0348735423.USD","LU0348784397.USD","LU0634319403.HKD","LU0828237510.HKD","LU0348827113.USD","LU2097828805.USD","LU2097828557.USD","KURE","LU1303224171.USD","06160","ONC","LU2399975544.HKD","09926","LU2242644610.SGD","BK1161","BK1587","LU0417516571.SGD","LU1770034418.SGD","09969","BK1191","BK1574","BK4526","LU2097828631.EUR","BK4588","LU0348767384.USD","LU0196878994.USD","LU2488822045.USD","LU0502904849.HKD","LU0348825331.USD","LU0540923850.HKD","LU2328871848.SGD","00013","01877","LU0244354667.USD","LU0455707207.USD","LU2778985437.USD","06990","BK1515","IE00BPRC5H50.USD","LU0307460666.USD","LU0588546209.SGD","LU1969619763.USD","LU0417516902.SGD","BK4139","688235","LU2097828714.EUR","LU0417516738.SGD","BK1500","HK0000165453.HKD","LU1188198961.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":7,"totalSize":180,"code":"91000000","status":"200"}]}}